What Mesh Bio does
Mesh Bio is a predictive health analytics platform that helps healthcare providers in Asia automate health screening and spot chronic disease risk earlier. It is aimed at private clinics and healthcare providers, diagnostic laboratories, occupational health providers and pharma developers running clinical trials. The site names two products: DARA, for automated health screening with report generation, risk stratification, clinical decision support and workflow integration, and HealthVector, which models diabetes complications with disease progression modeling, personalised risk assessment, treatment optimisation and patient engagement tools. Conditions covered include diabetes, kidney disease, cardiovascular disease, hypertension and stroke. Solution pages cover health screening, result interpretation and referral. No prices are published; prospective customers book a free demo.
How Mesh Bio compares with its closest alternatives
None of the 5 closest alternatives has a free plan, and neither does Mesh Bio. 1 of the 5 offers an API, as Mesh Bio does. Mesh Bio offers a web app. Of the alternatives, all 5 offer a web app. Mesh Bio was founded in 2018; the alternatives were founded between 2022 and 2026. Mesh Bio is based in Singapore; all its 5 alternatives are in Singapore too.